Chembio Diagnostic Systems, Inc. is a leading point-of-care diagnostics company focused on detecting and diagnosing infectious diseases. The company’s patented DPP technology platform, which uses a small drop of blood from the fingertip, provides high-quality, cost-effective results in 15-20 minutes. Coupled with Chembioʼs extensive scientific expertise, its novel DPP technology offers broad market applications beyond infectious disease, a number of which are under active development with collaboration partners. Chembioʼs products are sold globally, directly and through distributors, to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. Headquartered in Medford, NY, Chembio is registered with the U.S. Food and Drug Administration (FDA) as well as the U.S. Department of Agriculture (USDA), and is certified for the global market under the International Standards Organization (ISO) directive 13485. Learn more at www.chembio.com.
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com.
ViiV Healthcare is a global specialist HIV company established in November 2009 by GlaxoSmithKline (LSE: GSK) and Pfizer (NYSE: PFE) dedicated to delivering advances in treatment and care for people living with HIV and for people who are at risk of becoming infected with HIV. Shionogi joined in October 2012. The company’s aim is to take a deeper and broader interest in HIV/AIDS than any company has done before and take a new approach to deliver effective and innovative medicines for HIV treatment and prevention, as well as support communities affected by HIV.For more information on the company, its management, portfolio, pipeline, and commitment, please visit www.viivhealthcare.com.
The Society for AIDS Care, established in November 1994, is the first non-governmental organization in Asia providing high quality direct patient care services to children, adults and elderly people living with HIV/AIDS (PLWHA) and their care-givers in the community. Our professional team consists of nurses, social workers, counselors and physiotherapists. We provide both outreach and center-based services, including drug supervision, therapeutic counseling, psychological support, physiotherapy, peers support, public education and volunteers training. We are committed to provide professional services to PLWHA to strengthen their self-care ability and self-confidence to facilitate full community reintegration. Our unique Free Women Hotline and HIV and Syphilis Testing Service is helping many women in need. A new program providing preventive HIV/AIDS and STI education for Transgender persons and their sex partners with free HIV antibody and syphilis testing service helps to linkup early testing and early treatment.
|The Liverpool Drug Interactions Group at the University of Liverpool provides web and app resources enabling users to check for drug interactions with commonly prescribed co-medications. Our first website, www.hiv-druginteractions.org, for interactions with HIV therapy was launched in 1999, and this has been followed by websites for hepatitis therapy in 2011 (www.hep-druginteractions.org) and cancer therapy in 2017 (www.cancer-druginteractions.org), in association with Radboud UMC).|
In a world impacted by major technological and social disruptions "Youth against AIDS" goes new ways to face the HIV & STI epidemic among young generations. "Youth against AIDS" is convinced that great innovations are necessary to meet the needs of the young target group, and to become a close partner in young peoples lifes. "Youth against AIDS" builds networks to create innovation in prevention and to create a major change in young peoples individual health management.
PREVENTION is a clinical and implementing research unit under the Thai Red Cross AIDS Research Centre. We strive to be a leader in research and innovation concerning prevention of HIV and other health priorities, based on equity and community partnership, in order to advocate for the health-for-all policy changes and accelerate the progress to ending AIDS in Thailand. PREVENTION is pioneering the Key Population-Led Health Services model to empower lay providers who are members of key populations to provide HIV testing, pre-exposure prophylaxis (PrEP) and linkage to HIV care for their own communities. Our innovation also includes the Same-Day ART Initiation model which provides antiretroviral treatment on the same day as HIV diagnosis. To address the lacking transgender-competent health care, PREVENTION established the Tangerine Community Health Clinic, the first sexual health clinic exclusively for transgender people in Thailand.
Book a space
The APACC 2019 offers a unique opportunity to both commercial and non-commercial organizations to showcase their products and services to the regional leading professionals in the field of HIV/AIDS and co-infections. Delegates will comprise clinicians, researchers, scientists and other healthcare providers. Your organization cannot afford to miss the chance to reach the key players in Asia and the Pacific. The exhibition area will be located near the plenary session room and includes a coffee area ensuring a constant flow.
The prices indicated below are per square metre “bare floor space”, excluding. VAT. Titanium, platinum, gold sponsors are entitled to an additional discount. Additional shell scheme packages are available upon request.
Type of organization
(before 31 January 2019)
(before 1 May 2019)
(on/after 1 May 2018)
FLOOR SPACE ALLOCATION
Floor spaces are assigned according to the level of sponsorship until 1 December 2017. After this date the remaining space is assigned on the basis of the following order: 1) the level of sponsorships, 2) the size of purchased space, and 3) the date of payment received.
Only fully completed exhibition space orders will be accepted. The exhibition space order will only be confirmed upon receipt of payment in full accordance with the general terms and conditions. The organizers reserve the right to accept or reject applications and to assign spaces. Spaces will be grouped according to type of organization and standard guidelines. exhibitor entitlements and benefits.
Each exhibitor will receive a limited number of free badges based on the number of purchased quare meters according to the ratio outlined below. Additional exhibitor badges can be purchased for $ 495 per badge.
Purchased square meters
Complementary exhibitor passes
Up to 25 sqm
From 26 to 50 sqm
From 51 to 75 sqm
From 76 to 100 sqm
More than 100 sqm
To apply for exhibition space or shell scheme packages, please contact Mr. Kun-Chieh Wu at firstname.lastname@example.org or +31 30 230 7140.
Download the Technical Manual for exhibitors, symposium organizers and sponsors.
Additional forms for exhibitors:
- Form 1: Additional Furniture Facilities Form (for all exhibitors who wish to rent additional furniture)
- Form 2: Additional Electricity Facilities Form (for all exhibitors who wish to rent additional electricity facilities)
- Form 3: Raw Space Electricity Supply Facilities Form (for raw space exhibitors only)
- Form 4: Raw Space Exhibitor Submission Form for refuse & security deposit and plans & design proposals (for raw space exhibitors only)
- Form 5: Fascia Name Submission Form (for shell scheme exhibitors only)